Dyssynergia Cerebellaris Myoclonica Information Page

Dyssynergia Cerebellaris Myoclonica Information Page


What research is being done?

The NINDS supports a broad range of research on neurodegenerative disorders such as Dyssynergia Cerebellaris Myoclonica.  The goals of this research are to find ways to prevent, treat, and cure these kinds of disorders.

Information from the National Library of Medicine’s MedlinePlus
Cerebellar Disorders

×
What research is being done?

The NINDS supports a broad range of research on neurodegenerative disorders such as Dyssynergia Cerebellaris Myoclonica.  The goals of this research are to find ways to prevent, treat, and cure these kinds of disorders.

Information from the National Library of Medicine’s MedlinePlus
Cerebellar Disorders

The NINDS supports a broad range of research on neurodegenerative disorders such as Dyssynergia Cerebellaris Myoclonica.  The goals of this research are to find ways to prevent, treat, and cure these kinds of disorders.

Information from the National Library of Medicine’s MedlinePlus
Cerebellar Disorders

Search Disorders

Definition
Definition
Treatment
Treatment
Prognosis
Prognosis
Clinical Trials
Clinical Trials
Organizations
Organizations
Publications
Publications
Definition
Definition

Dyssynergia Cerebellaris Myoclonica refers to a collection of rare, degenerative, neurological disorders characterized by epilepsy, cognitive impairment, myoclonus, and progressive ataxia.  Symptoms include seizures, tremor, and reduced muscle coordination.  Onset of the disorder generally occurs in early adulthood.  Tremor may begin in one extremity and later spread to involve the entire voluntary muscular system.  Arms are usually more affected than legs.  Some of the cases are due to mitochondrial abnormalities.

×
Definition

Dyssynergia Cerebellaris Myoclonica refers to a collection of rare, degenerative, neurological disorders characterized by epilepsy, cognitive impairment, myoclonus, and progressive ataxia.  Symptoms include seizures, tremor, and reduced muscle coordination.  Onset of the disorder generally occurs in early adulthood.  Tremor may begin in one extremity and later spread to involve the entire voluntary muscular system.  Arms are usually more affected than legs.  Some of the cases are due to mitochondrial abnormalities.

Treatment
Treatment

Treatment of Dyssynergia Cerebellaris Myoclonica is symptomatic.  Myoclonus and seizures may be treated with drugs like valproate.

×
Treatment

Treatment of Dyssynergia Cerebellaris Myoclonica is symptomatic.  Myoclonus and seizures may be treated with drugs like valproate.

Definition
Definition

Dyssynergia Cerebellaris Myoclonica refers to a collection of rare, degenerative, neurological disorders characterized by epilepsy, cognitive impairment, myoclonus, and progressive ataxia.  Symptoms include seizures, tremor, and reduced muscle coordination.  Onset of the disorder generally occurs in early adulthood.  Tremor may begin in one extremity and later spread to involve the entire voluntary muscular system.  Arms are usually more affected than legs.  Some of the cases are due to mitochondrial abnormalities.

Treatment
Treatment

Treatment of Dyssynergia Cerebellaris Myoclonica is symptomatic.  Myoclonus and seizures may be treated with drugs like valproate.

Prognosis
Prognosis

The progression of the disorder is usually 10 years or longer.

×

The progression of the disorder is usually 10 years or longer.

Prognosis
Prognosis

The progression of the disorder is usually 10 years or longer.

Definition

Dyssynergia Cerebellaris Myoclonica refers to a collection of rare, degenerative, neurological disorders characterized by epilepsy, cognitive impairment, myoclonus, and progressive ataxia.  Symptoms include seizures, tremor, and reduced muscle coordination.  Onset of the disorder generally occurs in early adulthood.  Tremor may begin in one extremity and later spread to involve the entire voluntary muscular system.  Arms are usually more affected than legs.  Some of the cases are due to mitochondrial abnormalities.

Treatment

Treatment of Dyssynergia Cerebellaris Myoclonica is symptomatic.  Myoclonus and seizures may be treated with drugs like valproate.

Prognosis

The progression of the disorder is usually 10 years or longer.

What research is being done?

The NINDS supports a broad range of research on neurodegenerative disorders such as Dyssynergia Cerebellaris Myoclonica.  The goals of this research are to find ways to prevent, treat, and cure these kinds of disorders.

Information from the National Library of Medicine’s MedlinePlus
Cerebellar Disorders

Patient Organizations
National Ataxia Foundation (NAF)
2600 Fernbrook Lane North
Suite 119
Minneapolis
MN
Minneapolis, MN 55447-4752
Tel: 763-553-0020
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institutes of Health, DHHS
31 Center Drive, MSC 2320
Bethesda
MD
Bethesda, MD 20892-2320
Tel: 301-496-7243; 800-241-1044; 800-241-1055 (TTY)
National Organization for Rare Disorders (NORD)
55 Kenosia Avenue
Danbury
CT
Danbury, CT 06810
Tel: 203-744-0100; Voice Mail: 800-999-NORD (6673)
Patient Organizations